Chris Gale | GMC# 6052486

  • Imperial College London, Chelsea and Westminster Hospital NHS Foundation Trust
  • Reader in Neonatal Medicine and honorary consultant neonatologist

Archived Declarations


Sept. 23, 2019

Nothing To Declare



March 7, 2019

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Chiesi Pharmaceuticals Travel and accommodation to attend and speak at an educational conference - Neonatal Discussion Forum 2019 2

Dec. 5, 2018

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Chiesi Pharmaceuticals Travel and accommodation to attend an educational conference (The Neonate 2018) 3

Research grants paid by private institutions to your department


Company Reason for receipt of fees Total amount received
Chiesi Pharmaceuticals To develop and undertake the OPTISURF study: Optimising surfactant delivery for preterm babies born below 37 weeks gestation in the UK, using national data from the National Neonatal Research Database £100000+

March 11, 2016

Nothing To Declare



Dec. 2, 2015

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Chiesi Ltd Travel, accommodation and subsistence to attend the Neonatal Hot Topics Conference 2015 via the British Association of Perinatal Medicine travel bursary which is supported by Chiesi Ltd. 3
Chiesi Ltd Travel, accommodation and subsistence to attend the EAPS 2014 Conference via the British Association of Perinatal Medicine travel bursary which is supported by Chiesi Ltd. 3
Pfizer Nutrition Travel, accommodation and subsistence to attend the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Conference 2011 3